Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CRMD
CRMD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CRMD News
CorMedix to Report Q1 2026 Financial Results on May 14
5d ago
Newsfilter
Positive Trial Results for Rezzayo Antifungal Drug
Apr 27 2026
stocktwits
CorMedix Reports Positive Phase III Results for REZZAYO in Fungal Disease Prevention
Apr 27 2026
NASDAQ.COM
CorMedix Announces Positive Phase III Results for REZZAYO
Apr 27 2026
Newsfilter
CorMedix to Participate in Needham Conference
Apr 07 2026
Newsfilter
CorMedix Reports 2025 Financial Results and Guidance
Mar 06 2026
NASDAQ.COM
CorMedix Q4 2025 Earnings Call Insights
Mar 05 2026
seekingalpha
CorMedix Q4 2025 Earnings Misses Expectations
Mar 05 2026
seekingalpha
CorMedix Reports Q4 Revenue Surge Amid Mixed Earnings
Mar 05 2026
stocktwits
CORMEDIX Q4 OPERATING EXPENSES REVISED TO USD 48.182 MILLION
Mar 05 2026
moomoo
CorMedix Q4 Earnings Beat Expectations, Share Buyback Plan Approved
Mar 05 2026
seekingalpha
CorMedix Reports Significant Q4 Profit Growth
Mar 05 2026
NASDAQ.COM
CorMedix Reports Strong Q4 and Full-Year 2025 Financial Results
Mar 05 2026
Newsfilter
CorMedix Scheduled to Announce Q4 Earnings on March 5th
Mar 04 2026
seekingalpha
CorMedix to Present at Upcoming Investor Conferences
Feb 12 2026
Newsfilter
CorMedix's Near-Term Growth Prospects Analysis
Feb 11 2026
Yahoo Finance
Show More News